Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Body | 51 | 2025 | 246 | 10.450 |
Why?
|
| Hypoxia | 53 | 2025 | 682 | 6.580 |
Why?
|
| Hydrogen Sulfide | 11 | 2025 | 54 | 2.780 |
Why?
|
| Receptors, Odorant | 4 | 2023 | 38 | 2.170 |
Why?
|
| Oxygen | 14 | 2023 | 773 | 1.970 |
Why?
|
| Hypertension | 11 | 2025 | 788 | 1.960 |
Why?
|
| Sympathetic Nervous System | 4 | 2025 | 100 | 1.900 |
Why?
|
| Cystathionine gamma-Lyase | 9 | 2021 | 35 | 1.630 |
Why?
|
| Sleep Apnea Syndromes | 6 | 2023 | 109 | 1.450 |
Why?
|
| Adrenal Medulla | 9 | 2024 | 49 | 1.440 |
Why?
|
| Rats, Sprague-Dawley | 32 | 2025 | 1255 | 1.360 |
Why?
|
| Carbon Monoxide | 5 | 2022 | 98 | 1.340 |
Why?
|
| Oxidative Stress | 9 | 2015 | 489 | 1.310 |
Why?
|
| Rats | 36 | 2025 | 4074 | 1.250 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 229 | 1.200 |
Why?
|
| Reactive Oxygen Species | 16 | 2022 | 525 | 1.090 |
Why?
|
| Animals | 68 | 2025 | 28981 | 0.970 |
Why?
|
| Gasotransmitters | 4 | 2023 | 14 | 0.950 |
Why?
|
| NADPH Oxidases | 4 | 2014 | 87 | 0.940 |
Why?
|
| Respiration | 11 | 2023 | 272 | 0.890 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2025 | 21 | 0.890 |
Why?
|
| Heme Oxygenase (Decyclizing) | 8 | 2021 | 46 | 0.870 |
Why?
|
| Fentanyl | 1 | 2025 | 94 | 0.830 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 204 | 0.740 |
Why?
|
| Mice, Knockout | 14 | 2025 | 2212 | 0.730 |
Why?
|
| Carbonic Anhydrases | 1 | 2022 | 16 | 0.730 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2015 | 176 | 0.700 |
Why?
|
| Reflex | 8 | 2022 | 82 | 0.660 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2020 | 17 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3616 | 0.620 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 542 | 0.620 |
Why?
|
| Mice | 24 | 2025 | 12735 | 0.610 |
Why?
|
| Signal Transduction | 6 | 2025 | 3633 | 0.590 |
Why?
|
| Respiratory Mechanics | 3 | 2013 | 109 | 0.580 |
Why?
|
| Sulfites | 1 | 2018 | 37 | 0.550 |
Why?
|
| Apnea | 5 | 2019 | 36 | 0.540 |
Why?
|
| Catecholamines | 7 | 2021 | 93 | 0.530 |
Why?
|
| Sensory Receptor Cells | 1 | 2018 | 40 | 0.520 |
Why?
|
| Blood Pressure | 12 | 2018 | 920 | 0.500 |
Why?
|
| Sensation | 1 | 2017 | 49 | 0.490 |
Why?
|
| Chemoreceptor Cells | 9 | 2014 | 65 | 0.480 |
Why?
|
| Neuronal Plasticity | 5 | 2013 | 200 | 0.470 |
Why?
|
| Male | 41 | 2025 | 47263 | 0.470 |
Why?
|
| Carotid Sinus | 3 | 2011 | 19 | 0.450 |
Why?
|
| Endothelin-1 | 2 | 2013 | 42 | 0.440 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 41 | 0.440 |
Why?
|
| Medulla Oblongata | 5 | 2023 | 92 | 0.430 |
Why?
|
| Splanchnic Nerves | 3 | 2014 | 8 | 0.430 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2006 | 33 | 0.420 |
Why?
|
| Norepinephrine | 6 | 2024 | 166 | 0.400 |
Why?
|
| Pressoreceptors | 2 | 2011 | 12 | 0.400 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 54 | 0.390 |
Why?
|
| Metalloendopeptidases | 1 | 2013 | 44 | 0.390 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 69 | 0.390 |
Why?
|
| Erythropoietin | 2 | 2024 | 90 | 0.370 |
Why?
|
| Serotonin | 3 | 2009 | 211 | 0.340 |
Why?
|
| Angiotensin II | 1 | 2011 | 96 | 0.330 |
Why?
|
| Animals, Newborn | 6 | 2019 | 526 | 0.330 |
Why?
|
| Chronic Disease | 7 | 2021 | 988 | 0.320 |
Why?
|
| Hypoxia-Inducible Factor 1 | 5 | 2020 | 43 | 0.320 |
Why?
|
| Action Potentials | 5 | 2018 | 611 | 0.310 |
Why?
|
| Chromaffin Cells | 2 | 2021 | 36 | 0.310 |
Why?
|
| Oxygen Consumption | 4 | 2017 | 239 | 0.300 |
Why?
|
| Calcium | 5 | 2018 | 1203 | 0.290 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2006 | 49 | 0.280 |
Why?
|
| Phrenic Nerve | 4 | 2018 | 49 | 0.270 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2577 | 0.270 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 72 | 0.240 |
Why?
|
| Epinephrine | 2 | 2024 | 91 | 0.230 |
Why?
|
| Calcium Channels, T-Type | 2 | 2015 | 25 | 0.220 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2024 | 39 | 0.210 |
Why?
|
| Adenylyl Cyclases | 1 | 2025 | 105 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2022 | 2070 | 0.210 |
Why?
|
| Cyclic AMP | 1 | 2025 | 277 | 0.210 |
Why?
|
| Altitude Sickness | 1 | 2004 | 13 | 0.200 |
Why?
|
| Hypercapnia | 2 | 2022 | 50 | 0.190 |
Why?
|
| Superoxide Dismutase | 4 | 2016 | 155 | 0.190 |
Why?
|
| Mitochondria | 3 | 2006 | 650 | 0.190 |
Why?
|
| Urethane | 1 | 2022 | 5 | 0.180 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2002 | 11 | 0.180 |
Why?
|
| Mole Rats | 1 | 2022 | 6 | 0.180 |
Why?
|
| Periodicity | 1 | 2003 | 115 | 0.180 |
Why?
|
| Enzyme Activation | 4 | 2013 | 679 | 0.180 |
Why?
|
| Cell Hypoxia | 3 | 2018 | 191 | 0.170 |
Why?
|
| Calpain | 2 | 2014 | 113 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 201 | 0.170 |
Why?
|
| Gases | 2 | 2018 | 31 | 0.160 |
Why?
|
| Brain Stem | 3 | 2018 | 167 | 0.160 |
Why?
|
| Metalloporphyrins | 2 | 2013 | 26 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1817 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2858 | 0.140 |
Why?
|
| Vasomotor System | 1 | 1998 | 13 | 0.140 |
Why?
|
| Receptors, GABA-A | 1 | 1998 | 38 | 0.140 |
Why?
|
| Alkynes | 1 | 2018 | 20 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2018 | 735 | 0.130 |
Why?
|
| Glycine | 1 | 2018 | 96 | 0.130 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 2 | 2009 | 14 | 0.130 |
Why?
|
| Rats, Inbred SHR | 1 | 2017 | 33 | 0.130 |
Why?
|
| Rats, Inbred WKY | 1 | 2017 | 31 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2009 | 267 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2015 | 304 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2016 | 42 | 0.120 |
Why?
|
| Humans | 21 | 2023 | 98370 | 0.120 |
Why?
|
| Electron Transport Complex I | 2 | 2018 | 36 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 589 | 0.110 |
Why?
|
| Plethysmography, Whole Body | 3 | 2011 | 9 | 0.110 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 17 | 0.110 |
Why?
|
| Electrophysiology | 3 | 2006 | 385 | 0.110 |
Why?
|
| Afferent Pathways | 3 | 2005 | 61 | 0.110 |
Why?
|
| Time Factors | 6 | 2009 | 5577 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2015 | 43 | 0.110 |
Why?
|
| Solitary Nucleus | 1 | 2014 | 23 | 0.110 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2014 | 3 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 418 | 0.100 |
Why?
|
| Arteries | 1 | 2015 | 172 | 0.100 |
Why?
|
| Antioxidants | 2 | 2013 | 236 | 0.100 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 2013 | 4 | 0.100 |
Why?
|
| Receptor, Endothelin A | 1 | 2013 | 21 | 0.100 |
Why?
|
| Calcium Channels | 1 | 2014 | 180 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 215 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 223 | 0.090 |
Why?
|
| Body Weight | 1 | 2014 | 456 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2011 | 779 | 0.090 |
Why?
|
| PC12 Cells | 3 | 2014 | 113 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 690 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2009 | 41 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2015 | 1145 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1568 | 0.090 |
Why?
|
| Gene Expression | 4 | 2016 | 1322 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 22 | 0.090 |
Why?
|
| Potassium Chloride | 1 | 2011 | 75 | 0.080 |
Why?
|
| Time | 1 | 2011 | 80 | 0.080 |
Why?
|
| Substance P | 1 | 2011 | 62 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2011 | 890 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2011 | 158 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 132 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2009 | 529 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1607 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 320 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2011 | 138 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2011 | 116 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 237 | 0.080 |
Why?
|
| Ketanserin | 2 | 2006 | 9 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Homeostasis | 1 | 2012 | 474 | 0.070 |
Why?
|
| Nerve Net | 1 | 2013 | 404 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 889 | 0.070 |
Why?
|
| Heart | 1 | 2012 | 527 | 0.070 |
Why?
|
| Hypoglossal Nerve | 2 | 2023 | 28 | 0.070 |
Why?
|
| Acclimatization | 2 | 2009 | 91 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2015 | 719 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 212 | 0.070 |
Why?
|
| Heart Rate | 2 | 2002 | 534 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2792 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2009 | 334 | 0.060 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2007 | 19 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2009 | 743 | 0.060 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 32 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 37 | 0.060 |
Why?
|
| Receptors, Serotonin | 1 | 2006 | 34 | 0.060 |
Why?
|
| Serotonin Antagonists | 1 | 2006 | 24 | 0.060 |
Why?
|
| Acetophenones | 1 | 2006 | 27 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2006 | 72 | 0.060 |
Why?
|
| Receptors, Glutamate | 2 | 2005 | 22 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 403 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2005 | 78 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 350 | 0.060 |
Why?
|
| Angiotensin I | 1 | 2005 | 7 | 0.060 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2005 | 11 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2005 | 341 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 59 | 0.050 |
Why?
|
| Lung | 1 | 2012 | 1408 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2005 | 66 | 0.050 |
Why?
|
| Hypotension | 1 | 2005 | 77 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2024 | 1721 | 0.050 |
Why?
|
| Sodium Cyanide | 1 | 2004 | 6 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2003 | 13 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2024 | 293 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 642 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 480 | 0.050 |
Why?
|
| Genes, fos | 1 | 2003 | 24 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 273 | 0.050 |
Why?
|
| Kynurenic Acid | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 573 | 0.050 |
Why?
|
| Long-Term Potentiation | 1 | 2003 | 51 | 0.050 |
Why?
|
| Lidocaine | 1 | 2002 | 62 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2023 | 193 | 0.040 |
Why?
|
| Recurrence | 1 | 2004 | 1264 | 0.040 |
Why?
|
| Baroreflex | 1 | 2020 | 8 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2014 | 304 | 0.040 |
Why?
|
| Female | 4 | 2021 | 51761 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2018 | 22 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 84 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 1998 | 14 | 0.030 |
Why?
|
| Bicuculline | 1 | 1998 | 18 | 0.030 |
Why?
|
| GABA Antagonists | 1 | 1998 | 26 | 0.030 |
Why?
|
| Strychnine | 1 | 1998 | 8 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 2005 | 945 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2020 | 391 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 209 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 755 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2016 | 11 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2016 | 27 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2016 | 26 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 46 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 13 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 35 | 0.030 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 13 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1268 | 0.030 |
Why?
|
| Dopamine | 2 | 2009 | 280 | 0.030 |
Why?
|
| Essential Hypertension | 1 | 2015 | 10 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 66 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 2439 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 118 | 0.030 |
Why?
|
| Sulfides | 1 | 2014 | 72 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 96 | 0.030 |
Why?
|
| Autonomic Nervous System | 2 | 2009 | 70 | 0.030 |
Why?
|
| Cysteine | 1 | 2015 | 150 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 447 | 0.030 |
Why?
|
| Vasodilation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 316 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2014 | 290 | 0.020 |
Why?
|
| Models, Biological | 1 | 2020 | 1805 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 154 | 0.020 |
Why?
|
| Arousal | 1 | 2013 | 177 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 42 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1290 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2011 | 36 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 64 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 218 | 0.020 |
Why?
|
| Bradycardia | 1 | 2011 | 51 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 281 | 0.020 |
Why?
|
| CpG Islands | 1 | 2012 | 177 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 122 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 143 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2009 | 205 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 664 | 0.020 |
Why?
|
| Superoxides | 1 | 2006 | 76 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 311 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2006 | 73 | 0.010 |
Why?
|
| Taurine | 1 | 2005 | 8 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 74 | 0.010 |
Why?
|
| Microinjections | 1 | 2005 | 67 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2005 | 5 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 2005 | 6 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 19 | 0.010 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2005 | 6 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 56 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2005 | 60 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2005 | 35 | 0.010 |
Why?
|
| Tidal Volume | 1 | 2005 | 62 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 193 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 1561 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2005 | 136 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2005 | 87 | 0.010 |
Why?
|
| Nicotine | 1 | 2006 | 218 | 0.010 |
Why?
|
| Wakefulness | 1 | 2005 | 127 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 860 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2005 | 382 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 307 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2005 | 407 | 0.010 |
Why?
|
| Neurons | 2 | 2005 | 1626 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 2023 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 770 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 6273 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2002 | 46 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1947 | 0.010 |
Why?
|
| Heart Failure | 1 | 2011 | 1502 | 0.010 |
Why?
|
| Heterozygote | 1 | 2002 | 392 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 2551 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1892 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1999 | 68 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 29587 | 0.000 |
Why?
|